Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease.

Muñoz-Esquerre M, López-Sánchez M, Escobar I, Huertas D, Penín R, Molina-Molina M, Manresa F, Dorca J, Santos S.

PLoS One. 2016 Apr 5;11(4):e0152987. doi: 10.1371/journal.pone.0152987. eCollection 2016.

2.

Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction.

López-Sánchez M, Muñoz-Esquerre M, Huertas D, Montes A, Molina-Molina M, Manresa F, Dorca J, Santos S.

Clin Respir J. 2017 Nov;11(6):859-866. doi: 10.1111/crj.12428. Epub 2016 Jan 6.

PMID:
26663885
3.

Erratum to: Fibroblast viability and phenotypic changes within glycated stiffened three-dimensional collagen matrices.

Vicens-Zygmunt V, Estany S, Colom A, Montes-Worboys A, Machahua C, Sanabria AJ, Llatjos R, Escobar I, Manresa F, Dorca J, Navajas D, Alcaraz J, Molina-Molina M.

Respir Res. 2015 Nov 2;16:136. doi: 10.1186/s12931-015-0277-4. No abstract available.

4.

Fibroblast viability and phenotypic changes within glycated stiffened three-dimensional collagen matrices.

Vicens-Zygmunt V, Estany S, Colom A, Montes-Worboys A, Machahua C, Sanabria AJ, Llatjos R, Escobar I, Manresa F, Dorca J, Navajas D, Alcaraz J, Molina-Molina M.

Respir Res. 2015 Jul 1;16:82. doi: 10.1186/s12931-015-0237-z. Erratum in: Respir Res. 2015;16:136.

5.

Gene and Protein Expression of Fibronectin and Tenascin-C in Lung Samples from COPD Patients.

Muñoz-Esquerre M, Huertas D, Escobar I, López-Sánchez M, Penín R, Peinado V, Barberà JA, Molina-Molina M, Manresa F, Dorca J, Santos S.

Lung. 2015 Jun;193(3):335-43. doi: 10.1007/s00408-015-9717-7. Epub 2015 Mar 21.

PMID:
25794567
6.

Roflumilast added to triple therapy in patients with severe COPD: a real life study.

Muñoz-Esquerre M, Diez-Ferrer M, Montón C, Pomares X, López-Sánchez M, Huertas D, Manresa F, Dorca J, Santos S.

Pulm Pharmacol Ther. 2015 Feb;30:16-21. doi: 10.1016/j.pupt.2014.10.002. Epub 2014 Oct 30.

PMID:
25445930
7.

Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.

Estany S, Vicens-Zygmunt V, Llatjós R, Montes A, Penín R, Escobar I, Xaubet A, Santos S, Manresa F, Dorca J, Molina-Molina M.

BMC Pulm Med. 2014 Jul 26;14:120. doi: 10.1186/1471-2466-14-120.

8.

High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study.

López-Sánchez M, Muñoz-Esquerre M, Huertas D, Gonzalez-Costello J, Ribas J, Manresa F, Dorca J, Santos S.

PLoS One. 2013 Jun 27;8(6):e68034. doi: 10.1371/journal.pone.0068034. Print 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/b4120833-e4c6-42b5-92e9-24c396f9444e.

9.

Prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia.

Viasus D, Garcia-Vidal C, Simonetti A, Manresa F, Dorca J, Gudiol F, Carratalà J.

J Infect. 2013 May;66(5):415-23. doi: 10.1016/j.jinf.2012.12.007. Epub 2012 Dec 31.

PMID:
23286966
10.

Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years.

Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J.

Medicine (Baltimore). 2013 Jan;92(1):51-60. doi: 10.1097/MD.0b013e31827f6104.

11.

Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia.

Viasus D, Garcia-Vidal C, Manresa F, Dorca J, Gudiol F, Carratalà J.

J Infect. 2013 Jan;66(1):27-33. doi: 10.1016/j.jinf.2012.09.003. Epub 2012 Sep 11.

PMID:
22981899
12.

Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial.

Carratalà J, Garcia-Vidal C, Ortega L, Fernández-Sabé N, Clemente M, Albero G, López M, Castellsagué X, Dorca J, Verdaguer R, Martínez-Montauti J, Manresa F, Gudiol F.

Arch Intern Med. 2012 Jun 25;172(12):922-8. doi: 10.1001/archinternmed.2012.1690.

PMID:
22732747
13.

Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia.

Simonetti A, Viasus D, Garcia-Vidal C, Adamuz J, Roset A, Manresa F, Dorca J, Gudiol F, Carratalà J.

Clin Microbiol Infect. 2012 Nov;18(11):1149-55. doi: 10.1111/j.1469-0691.2011.03709.x. Epub 2011 Nov 24.

14.

Dasatinib as salvage therapy for steroid refractory and imatinib resistant or intolerant sclerotic chronic graft-versus-host disease.

Sánchez-Ortega I, Servitje O, Arnan M, Ortí G, Peralta T, Manresa F, Duarte RF.

Biol Blood Marrow Transplant. 2012 Feb;18(2):318-23. doi: 10.1016/j.bbmt.2011.10.042. Epub 2011 Nov 7.

15.

Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial.

Fernández-Serrano S, Dorca J, Garcia-Vidal C, Fernández-Sabé N, Carratalà J, Fernández-Agüera A, Corominas M, Padrones S, Gudiol F, Manresa F.

Crit Care. 2011 Mar 15;15(2):R96. doi: 10.1186/cc10103.

16.

Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores.

Viasus D, Garcia-Vidal C, Castellote J, Adamuz J, Verdaguer R, Dorca J, Manresa F, Gudiol F, Carratalà J.

Medicine (Baltimore). 2011 Mar;90(2):110-8. doi: 10.1097/MD.0b013e318210504c.

17.

Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis.

Berlana D, Llop JM, Manresa F, Jódar R.

Pharmacotherapy. 2011 Feb;31(2):146-57. doi: 10.1592/phco.31.2.146.

PMID:
21275493
18.

Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease.

Viasus D, Garcia-Vidal C, Cruzado JM, Adamuz J, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J.

Nephrol Dial Transplant. 2011 Sep;26(9):2899-906. doi: 10.1093/ndt/gfq798. Epub 2011 Jan 27.

PMID:
21273232
19.

Impact of antibiotic therapy on systemic cytokine expression in pneumococcal pneumonia.

Padrones S, Garcia-Vidal C, Fernández-Serrano S, Fernández A, Masuet C, Carratalà J, Coromines M, Ardanuy C, Gudiol F, Manresa F, Dorca J.

Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1243-51. doi: 10.1007/s10096-010-0993-0. Epub 2010 Jun 22.

20.

Aetiology of, and risk factors for, recurrent community-acquired pneumonia.

Garcia-Vidal C, Carratalà J, Fernández-Sabé N, Dorca J, Verdaguer R, Manresa F, Gudiol F.

Clin Microbiol Infect. 2009 Nov;15(11):1033-8. doi: 10.1111/j.1469-0691.2009.02918.x. Epub 2009 Aug 8.

21.

[Factors associated with prolonged hospital stay in community-acquired pneumonia].

Garcia-Vidal C, Carratalà J, Díaz V, Dorca J, Verdaguer R, Manresa F, Gudiol F.

Enferm Infecc Microbiol Clin. 2009 Mar;27(3):160-4. doi: 10.1016/j.eimc.2008.06.004. Epub 2009 Feb 11. Spanish.

PMID:
19306716
22.

Early mortality in patients with community-acquired pneumonia: causes and risk factors.

Garcia-Vidal C, Fernández-Sabé N, Carratalà J, Díaz V, Verdaguer R, Dorca J, Manresa F, Gudiol F.

Eur Respir J. 2008 Sep;32(3):733-9. doi: 10.1183/09031936.00128107. Epub 2008 May 28.

23.

Volumetric capnography and chronic obstructive pulmonary disease staging.

Romero PV, Rodriguez B, de Oliveira D, Blanch L, Manresa F.

Int J Chron Obstruct Pulmon Dis. 2007;2(3):381-91.

24.

Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes.

Carratalà J, Mykietiuk A, Fernández-Sabé N, Suárez C, Dorca J, Verdaguer R, Manresa F, Gudiol F.

Arch Intern Med. 2007 Jul 9;167(13):1393-9.

PMID:
17620533
25.

Outcome of non-invasive domiciliary ventilation in elderly patients.

Farrero E, Prats E, Manresa F, Escarrabill J.

Respir Med. 2007 Jun;101(6):1068-73. Epub 2006 Nov 28.

26.

Noninvasive positive pressure ventilation prevents postoperative pulmonary complications in chronic ventilators users.

Lumbierres M, Prats E, Farrero E, Monasterio C, Gracia T, Manresa F, Escarrabill J.

Respir Med. 2007 Jan;101(1):62-8. Epub 2006 Jun 13.

27.

Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia.

Mykietiuk A, Carratalà J, Domínguez A, Manzur A, Fernández-Sabé N, Dorca J, Tubau F, Manresa F, Gudiol F.

Eur J Clin Microbiol Infect Dis. 2006 Jul;25(7):457-62.

PMID:
16773389
28.

[Analysis of oxidative stress in exhaled breath condensate from patients with severe pulmonary infections].

Romero PV, Rodríguez B, Martínez S, Cañizares R, Sepúlveda D, Manresa F.

Arch Bronconeumol. 2006 Mar;42(3):113-9. Spanish.

29.

Survival in amyotrophic lateral sclerosis with home mechanical ventilation: the impact of systematic respiratory assessment and bulbar involvement.

Farrero E, Prats E, Povedano M, Martinez-Matos JA, Manresa F, Escarrabill J.

Chest. 2005 Jun;127(6):2132-8.

PMID:
15947331
30.

Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy.

Mykietiuk A, Carratalà J, Fernández-Sabé N, Dorca J, Verdaguer R, Manresa F, Gudiol F.

Clin Infect Dis. 2005 Mar 15;40(6):794-9. Epub 2005 Feb 17.

PMID:
15736010
31.

Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients.

Carratalà J, Fernández-Sabé N, Ortega L, Castellsagué X, Rosón B, Dorca J, Fernández-Agüera A, Verdaguer R, Martínez J, Manresa F, Gudiol F.

Ann Intern Med. 2005 Feb 1;142(3):165-72.

PMID:
15684204
32.

Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia.

Rosón B, Carratalà J, Fernández-Sabé N, Tubau F, Manresa F, Gudiol F.

Arch Intern Med. 2004 Mar 8;164(5):502-8.

PMID:
15006826
33.

Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia.

Rosón B, Fernández-Sabé N, Carratalà J, Verdaguer R, Dorca J, Manresa F, Gudiol F.

Clin Infect Dis. 2004 Jan 15;38(2):222-6. Epub 2003 Dec 18.

PMID:
14699454
34.

Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia.

Fernández-Serrano S, Dorca J, Coromines M, Carratalà J, Gudiol F, Manresa F.

Clin Diagn Lab Immunol. 2003 Sep;10(5):813-20.

35.

Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system.

Fernández-Sabé N, Rosón B, Carratalà J, Dorca J, Manresa F, Gudiol F.

Clin Infect Dis. 2003 Aug 15;37(4):483-9. Epub 2003 Jul 28.

PMID:
12905131
36.

Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes.

Fernández-Sabé N, Carratalà J, Rosón B, Dorca J, Verdaguer R, Manresa F, Gudiol F.

Medicine (Baltimore). 2003 May;82(3):159-69.

37.

Genetic characterization of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasis.

de la Campa AG, Ferrandiz MJ, Tubau F, Pallarés R, Manresa F, Liñares J.

Antimicrob Agents Chemother. 2003 Apr;47(4):1419-22.

38.

Efficacy and safety of sequential amoxicillin-clavulanate in the treatment of anaerobic lung infections.

Fernández-Sabé N, Carratalà J, Dorca J, Rosón B, Tubau F, Manresa F, Gudiol F.

Eur J Clin Microbiol Infect Dis. 2003 Mar;22(3):185-7. Epub 2003 Mar 5.

PMID:
12649717
39.

Neither questions nor answers, just original data.

Prats E, Dorca J, Manresa F.

Eur Respir J. 2003 Feb;21(2):377. No abstract available.

40.

Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia.

Prats E, Dorca J, Pujol M, Garcia L, Barreiro B, Verdaguer R, Gudiol F, Manresa F.

Eur Respir J. 2002 May;19(5):944-51.

41.

Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria.

Rosón B, Carratalà J, Dorca J, Casanova A, Manresa F, Gudiol F.

Clin Infect Dis. 2001 Jul 15;33(2):158-65. Epub 2001 Jun 15.

PMID:
11418874
42.

Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.

Rosón B, Carratalà J, Tubau F, Dorca J, Liñares J, Pallares R, Manresa F, Gudiol F.

Microb Drug Resist. 2001 Spring;7(1):85-96.

PMID:
11310807
43.

Impact of a hospital-based home-care program on the management of COPD patients receiving long-term oxygen therapy.

Farrero E, Escarrabill J, Prats E, Maderal M, Manresa F.

Chest. 2001 Feb;119(2):364-9.

PMID:
11171710
44.

Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization.

Rosón B, Carratalà J, Verdaguer R, Dorca J, Manresa F, Gudiol F.

Clin Infect Dis. 2000 Oct;31(4):869-74. Epub 2000 Oct 12.

PMID:
11049763
45.

[Effectiveness of a mandibular advancement prosthesis in the treatment of obstructive sleep apnea syndrome].

Monasterio C, Navarro A, Farreras S, Marí A, Brinquis T, Estopà R, Manresa F.

Arch Bronconeumol. 2000 Jul-Aug;36(7):371-6. Spanish.

46.

Management of infectious pleural diseases.

Manresa F.

Monaldi Arch Chest Dis. 2000 Feb;55(1):20-4. No abstract available.

PMID:
10786420
47.

[The internal consistency and content validity of the Spanish version of the Asthma Autonomy Questionnaire].

Perpiñá M, Sobradillo V, Castillo J, Duce F, Manresa F, Martínez J, Valencia A, Viejo JL, Villasante C.

Arch Bronconeumol. 2000 Feb;36(2):90-4. Spanish.

48.

[Information seeking and decision making in asthmatic patients].

Perpiñá M, Sobradillo V, Castillo J, Duce F, Manresa F, Martínez J, Valencia A, Viejo JL, Villasante C.

Arch Bronconeumol. 1999 Oct;35(9):435-9. Spanish.

PMID:
10596340
49.

Löfgren's syndrome revisited: a study of 186 patients.

Mañá J, Gómez-Vaquero C, Montero A, Salazar A, Marcoval J, Valverde J, Manresa F, Pujol R.

Am J Med. 1999 Sep;107(3):240-5.

PMID:
10492317
50.

Microbial etiology and bacterial resistance.

Manresa F, Dorca J.

Semin Respir Infect. 1999 Jun;14(2):115-27. Review.

PMID:
10391406

Supplemental Content

Loading ...
Support Center